Ovarian cancer is a lethal gynecological cancer and The Cancer Genome Atlas (TCGA) data have revealed a hyperactivation of the PI3K-AKT-mTOR pathway in nearly 60% of patients with ovarian cancer. Here, MTOR is linked to ovarian cancer.